Compare with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM CIPLA OMKAR PHARMACHEM/
CIPLA
 
P/E (TTM) x 116.1 29.4 395.1% View Chart
P/BV x 2.5 4.1 60.3% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 OMKAR PHARMACHEM   CIPLA
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
CIPLA
Mar-21
OMKAR PHARMACHEM/
CIPLA
5-Yr Chart
Click to enlarge
High Rs21879 2.4%   
Low Rs16411 3.9%   
Sales per share (Unadj.) Rs0.3237.6 0.1%  
Earnings per share (Unadj.) Rs0.229.8 0.7%  
Cash flow per share (Unadj.) Rs0.243.0 0.5%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs8.6226.7 3.8%  
Shares outstanding (eoy) m10.08806.46 1.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.42.7 2,519.3%   
Avg P/E ratio x83.321.6 384.9%  
P/CF ratio (eoy) x82.915.0 553.5%  
Price / Book Value ratio x2.12.8 74.9%  
Dividend payout %016.8 0.0%   
Avg Mkt Cap Rs m185519,826 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m132,518 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3191,596 0.0%  
Other income Rs m02,698 0.0%   
Total revenues Rs m3194,294 0.0%   
Gross profit Rs m042,487 0.0%  
Depreciation Rs m010,677 0.0%   
Interest Rs m11,607 0.0%   
Profit before tax Rs m032,901 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-38,888 -0.0%   
Profit after tax Rs m224,013 0.0%  
Gross profit margin %8.122.2 36.4%  
Effective tax rate %714.727.0 2,645.8%   
Net profit margin %82.012.5 654.3%  
BALANCE SHEET DATA
Current assets Rs m1132,095 0.0%   
Current liabilities Rs m1045,916 0.0%   
Net working cap to sales %-332.145.0 -738.4%  
Current ratio x0.12.9 2.5%  
Inventory Days Days12,57268 18,582.6%  
Debtors Days Days3657 5,560.5%  
Net fixed assets Rs m93116,277 0.1%   
Share capital Rs m1011,613 6.3%   
"Free" reserves Rs m-14181,232 -0.0%   
Net worth Rs m87182,844 0.0%   
Long term debt Rs m012,028 0.0%   
Total assets Rs m94248,372 0.0%  
Interest coverage x0.421.5 1.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x00.8 3.7%   
Return on assets %3.010.3 28.8%  
Return on equity %2.613.1 19.5%  
Return on capital %0.217.7 1.4%  
Exports to sales %031.3 0.0%   
Imports to sales %010.9 0.0%   
Exports (fob) Rs mNA59,951 0.0%   
Imports (cif) Rs mNA20,911 0.0%   
Fx inflow Rs m068,051 0.0%   
Fx outflow Rs m020,911 0.0%   
Net fx Rs m047,140 0.0%   
CASH FLOW
From Operations Rs m037,552 0.0%  
From Investments Rs mNA-23,872 0.0%  
From Financial Activity Rs mNA-13,299 0.0%  
Net Cashflow Rs m0509 0.0%  

Share Holding

Indian Promoters % 0.0 13.5 0.2%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 0.0 48.6 -  
FIIs % 0.0 26.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 66.4 150.6%  
Shareholders   3,556 418,584 0.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    

Yellow Ad

Advertisement

Our FREE Guide: Small Caps That Will Race Ahead of the Sensex

Richa Agarwal, our head of smallcap research, recently released the updated version of her very popular guide:

'Small Caps That Will Race Ahead of the Sensex':

When you sign-up for Richa's One Stock Crorepati mega summit, you get this premium guide worth Rs 950 for absolutely FREE.:

Learn more



Today's Market

Why Auto Stocks are Rising, the Latest on Cryptos, and Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets rose for the third consecutive session, as prospects of a slowing economic growth fanned hopes that global central banks may go slow on interest rate hikes.

Related Views on News

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

India's Agriculture Focus: The Top Fertilizer Companies in India to Watch Out For (Views On News)

Jan 21, 2022

Top 5 fertiliser stocks that need to be in your watchlist for 2022.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OMKAR PHARMACHEM SHARE PRICE


May 10, 2022 (Close)

TRACK OMKAR PHARMACHEM

  • Track your investment in OMKAR PHARMACHEM with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON OMKAR PHARMACHEM

OMKAR PHARMACHEM 8-QTR ANALYSIS

COMPARE OMKAR PHARMACHEM WITH

MARKET STATS